TransCode Therapeutics Inc News - RNAZ

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

TransCode Therapeutics Announces Completion of Cohort 3 Initial Dosing with Lead Candidate in Phase 1 Clinical Trial

TransCode Therapeutics Announces Completion of Cohort 3 Initial Dosing with Lead Candidate in Phase 1 Clinical...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

TransCode Therapeutics, Inc. Announces Adjournment of Special Meeting and Information for Adjourned Special Meeting

TransCode Therapeutics, Inc. Announces Adjournment of Special Meeting and Information for Adjourned Special...

TransCode Therapeutics Announces First Patient Dosed in Third Cohort with Lead Candidate in Phase 1 Clinical Trial

TransCode Therapeutics Announces First Patient Dosed in Third Cohort with Lead Candidate in Phase 1 Clinical...

Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements

Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements PR...

Form DEF 14A - Other definitive proxy statements

Form 8-K - Current report

Form PRE 14A - Other preliminary proxy statements

TransCode Therapeutics Announces Safety Review Committee Approval of Opening Third Cohort and Preliminary Results from First Cohort in Phase 1 TTX-MC138 Clinical Trial

TransCode Therapeutics Announces Safety Review Committee Approval of Opening Third Cohort and Preliminary...

Is it monday yet..News could land on planet earth anytime now …
https://www.tipranks.com/news/ratings/promising-clinical-developments-drive-buy-rating-for-transcode-therapeutics

👍️0

MartinLutherKing 15 hours ago

Billion dollar market cap will land on planet earth and will rattle the world with the cure to cancer🚀🚀🚀🚀🚀

👍️0

MartinLutherKing 15 hours ago

The revolutionary TTX-CRISPR: A CRISPR/Cas9-based therapy platform for gene repair or elimination in tumor cells.

👍️0

MartinLutherKing 16 hours ago

TTX- stargate material TTX-MC138: A clinical stage product for treating metastatic cancer.
- TTX-siPDL1: An siRNA-based modulator targeting programmed death-ligand 1.
- TTX-siLIN28B: An siRNA-based inhibitor targeting RNA-binding protein LIN28B.
- TTX-RIGA: An RNA-based agonist for the RIG-I-driven immune response in the tumor microenvironment.
- TTX-CRISPR: A CRISPR/Cas9-based therapy platform for gene repair or elimination in tumor cells.
- TTX-mRNA: An mRNA-based platform for developing cancer vaccines.

👍️0

MartinLutherKing 16 hours ago

Nobel prize micro Rna breakthrough at the highest level of research
No safety concerns or dose limiting toxicities reported across all nine patients
TTX-MC138 achieved 66% inhibition of miR-10b at 24 hours post-infusion
Successful dose escalation with increased activity in Cohort 2
PK/PD profile consistent with preclinical and Phase 0 results
Multiple patients continuing treatment in 28-day cycles

👍️0

MartinLutherKing 18 hours ago

Stay tuned for news next week for the billion dollar market cap news🚀🚀🚀

👍️0

MetaMonster 23 hours ago

Criminal pedlar short motherfucker rat bastards are still in control till 100m market cap is obtained

👍️0

MartinLutherKing 23 hours ago

New tripple bottom foundation of all the nations🚀🚀🚀🚀

👍️0

MartinLutherKing 1 day ago

Green coming🚀🚀🚀

👍️0

MartinLutherKing 1 day ago

Load now strong hands in play 🚀🚀🚀🚀

👍️0

MartinLutherKing 1 day ago

It’s healthy to take a shit on all the nigga shorts,

👍️0

MartinLutherKing 1 day ago

Hold up the fort brother, Ai cure to cancer bots want your shares, hold on to your dirty underwears🚀🚀🚀🚀🚀

👍️0

Risk 1 day ago

Any idea why vol was so big last 2 days? Today no that much

👍️0

tapioca 1 day ago

Up and down like a yo-yo..

👍️0

MartinLutherKing 1 day ago

Ai Cure to cancer bots about to activate🚀🚀🚀

👍️0

MartinLutherKing 1 day ago

Get ready brothers🚀🚀🚀🚀

👍️0

MartinLutherKing 1 day ago

Consolidation of all the nations cancer cure earthquake going to hit planet earth

👍️0

MartinLutherKing 1 day ago

Gut it out brothers, squeeze time🚀🚀🚀🚀

👍️0

MartinLutherKing 1 day ago

Load up before the atomic bots take over the cure to cancer is here🚀🚀🚀🚀

👍️0

MartinLutherKing 1 day ago

Blink blink 100$

👍️0

MartinLutherKing 1 day ago

Let’s all hold hands and push to the next frontier of cancer research 🚀🚀🚀

👍️0

MetaMonster 1 day ago

A message to all the short criminal motherfucker rat bastards of the earth, who tried to sabotage the only hope for terminally ill cancer patients, eat shit motherfuckers

👍 1

MetaMonster 1 day ago

The cancer cure sabotage by big pharma rat bastard motherfuckers is over
https://nebraskajournalherald.substack.com/p/stargate-ais-cancer-cure-echoes-the

MartinLutherKing 1 day ago

The world is watching now…
TTX-MC138: A clinical stage product for treating metastatic cancer.
- TTX-siPDL1: An siRNA-based modulator of programmed death-ligand 1.
- TTX-siLIN28B: An siRNA-based inhibitor of RNA-binding protein LIN28B.
- TTX-RIGA: An RNA-based agonist of the RIG-I-driven immune response in the tumor microenvironment.
- TTX-CRISPR: A CRISPR/Cas9-based therapy platform for repairing or eliminating cancer-causing genes inside tumor cells.
- TTX-mRNA: An mRNA-based platform for developing cancer vaccines to activate cytotoxic immune responses against tumor cells.

👍️0

Money hunt 1 day ago

Goodmorning peeps, this is your captain speaking , fasten up your seatbelts and embrace yourselves for worldwide cancer cure impact

👍️0

MartinLutherKing 1 day ago

Cancer cure moment breakthrough🚀🚀 The holy grail in cancer treatment🚀🚀

👍️0

MartinLutherKing 1 day ago

You snooze you loose brothers🚀🚀🚀 take this to the bank 🚀🚀🚀
Analyses of PK data and pharmacodynamic (PD) activity from Cohorts 1 and 2 is ongoing. To date, the analyses suggest that TTX-MC138 demonstrates a PK/PD profile consistent with preclinical results and results from TransCode's previous Phase 0 clinical trial. Specifically, results from Cohort 1 confirmed the Phase 0 observation that TTX-MC138 shows evidence of pharmacodynamic activity in the presence of high baseline expression of miR-10b, reaching a 66% inhibition at 24 hours after infusion, similar to that seen in the Phase 0 trial. Additionally, TTX-MC138 activity increased with the escalated dose administered in Cohort 2 and was consistent at subsequent administrations suggesting a favorable pharmacokinetic profile.

👍️0

MartinLutherKing 1 day ago

Make no mistakes TransCode is a clinical-stage oncology company focused on treating metastatic disease. The company is committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics based on its proprietary TTX nanoparticle platform. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic tumors which overexpress microRNA-10b, a unique, well-documented biomarker of metastasis. In addition, TransCode has a portfolio of other first-in-class RNA therapeutic candidates designed to overcome the challenges of RNA delivery and thus unlock therapeutic access to a variety of novel genetic targets that could be relevant to treating a variety of cancers.

👍️0

MartinLutherKing 1 day ago

Hold on to your dirty underwears brothers, The cure to cancer is here Oracle's Larry Ellison Says Cancer Vaccine Tailored In 48 Hours Could Soon Be A Reality As Trump Announces $500 Billion AI Investment

co-founder Larry Ellison unveiled plans for an artificial intelligence-driven cancer vaccine system that could deliver personalized treatments within 48 hours, speaking at a White House briefing alongside tech leaders and President Donald Trump on Tuesday.

What Happened: The announcement came as part of a broader $500 billion AI infrastructure initiative called Stargate, a joint venture between Oracle, OpenAI, and SoftBank Group. The project will establish massive data centers across the United States, starting with a facility in Abilene, Texas.

“We can diagnose cancer using AI through a simple blood test,” Ellison explained during the briefing. “Once we sequence the genes of that cancer tumor, we can design an mRNA vaccine for each individual robotically using AI in about 48 hours.”
https://www.benzinga.com/markets/equities/25/01/43118941/oracles-larry-ellison-says-cancer-vaccine-tailored-in-48-hours-could-soon-be-a-reality-as-trump-announces-500-billion-ai-investment

👍️0

MartinLutherKing 1 day ago

Live the dream brothers
https://cloudwars.com/innovation-leadership/larry-ellison-and-stargate-ai-will-shatter-the-tyranny-of-impossible/

👍️0

MartinLutherKing 1 day ago

My texas cowboys🚀🚀Customised Cancer Treatment In 48 Hours? Trump’s $500B AI Plan Stargate Sparks Hopes
January 22, 2025, 13:02 IST
The project- named Stargate- was launched by OpenAI, SoftBank and Oracle in order to provide new technology with the help of large data centers based in Texas.

https://www.news18.com/amp/world/customised-cancer-treatment-in-48-hours-trumps-500b-ai-plan-stargate-sparks-hopes-and-debate-9197566.html

👍️0

MartinLutherKing 1 day ago

TTX-MC138 shows evidence of pharmacodynamic activity in the presence of high baseline expression of miR-10b, reaching a 66% inhibition at 24 hours after infusion, similar to that seen in the Phase 0 trial. Additionally, TTX-MC138 activity increased with the escalated dose administered in Cohort 2 and was consistent at subsequent administrations suggesting a favorable pharmacokinetic profile.

Ellison explained that Oracle was utilizing technology from Altman and Son’s companies to develop mRNA vaccines that are custom-tailored for every cancer patient that receives them. He claims this will eventually be made possible through AI examining a blood sample and developing a shot for the specific cancer within two days.
https://mugglehead.com/ai-behemoth-project-stargate-will-revolutionize-cancer-treatment-oracle-founder-ellison-says/?amp=1

👍️0

Ms Labonte 2 days ago

Next leg up $weet$$$

👍️0

Ms Labonte 2 days ago

Leg$ wide open and ready to $quirt to 20 buckarooo$$$. https://www.tipranks.com/news/ratings/promising-clinical-developments-drive-buy-rating-for-transcode-therapeutics

👍️0

Ms Labonte 2 days ago

11.11 Now connected to the universe $weet$$ love you$$$

👍️0

Ms Labonte 2 days ago

$how me the way $weet$$ Your mine$$$$

👍️0

Ms Labonte 2 days ago

Drop your pant$ $lap my a$$ junkie$$$ I got your back$$$
https://jonrappoport.substack.com/p/rna-cancer-vaccines-created-by-ai-for-500-billion-dollars?utm_campaign=post&utm_medium=web

👍️0

Money hunt 2 days ago

Fasten your seatbelts and embrace for impact, Blue skies up ahead dudes

👍️0

MartinLutherKing 2 days ago

Hold up the fort more news coming🚀🚀🚀🚀

👍️0

MartinLutherKing 2 days ago

Y’ all going to get a wake up call power hour🚀🚀🚀

👍️0

MartinLutherKing 2 days ago

It’s all in the pudding cure to cancer moment is here🚀🚀🚀Made in the USA

👍️0

Risk 2 days ago

I see $1000 with great news, look at the float, somebody decide to take it it will fly like a rocket ship.. off course my opinion

👍️0

MartinLutherKing 2 days ago

They can’t hold it down much longer🚀🚀🚀

👍️0

MartinLutherKing 2 days ago

100$ EOW Brother🚀🚀🚀🚀

👍️0

MartinLutherKing 2 days ago

They will only call when market cap is 8M with 696K outstanding 500k float trading 12M shares

👍️0

Tiger Money 2 days ago

Let's go back to $80,000 a share where we were 3 years ago. This thing is about to blow!

👍 1 🚀 1

MartinLutherKing 2 days ago

When they see it’s worth 1000$ a share they all want in

👍️0

MartinLutherKing 2 days ago

Don’t blink brother 100$ pop incoming

👍️0

MartinLutherKing 2 days ago

Hold up the fort brothers we going to the next level🚀🚀🚀

👍️0

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

TransCode Therapeutics Inc (RNAZ)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

RNAZ News

TransCode Therapeutics Announces Completion of Cohort 3 Initial Dosing with Lead Candidate in Phase 1 Clinical Trial

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

TransCode Therapeutics, Inc. Announces Adjournment of Special Meeting and Information for Adjourned Special Meeting

TransCode Therapeutics Announces First Patient Dosed in Third Cohort with Lead Candidate in Phase 1 Clinical Trial

Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements

Form DEF 14A - Other definitive proxy statements

Form 8-K - Current report

Form PRE 14A - Other preliminary proxy statements

TransCode Therapeutics Announces Safety Review Committee Approval of Opening Third Cohort and Preliminary Results from First Cohort in Phase 1 TTX-MC138 Clinical Trial

Form EFFECT - Notice of Effectiveness

Form D - Notice of Exempt Offering of Securities

Form S-1 - General form for registration of securities under the Securities Act of 1933

Form 8-K - Current report

TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split

RNAZ Discussion

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

TransCode Therapeutics Inc (RNAZ) News

TransCode Therapeutics Inc (RNAZ)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

RNAZ News

TransCode Therapeutics Announces Completion of Cohort 3 Initial Dosing with Lead Candidate in Phase 1 Clinical Trial

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

TransCode Therapeutics, Inc. Announces Adjournment of Special Meeting and Information for Adjourned Special Meeting

TransCode Therapeutics Announces First Patient Dosed in Third Cohort with Lead Candidate in Phase 1 Clinical Trial

Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements

Form DEF 14A - Other definitive proxy statements

Form 8-K - Current report

Form PRE 14A - Other preliminary proxy statements

TransCode Therapeutics Announces Safety Review Committee Approval of Opening Third Cohort and Preliminary Results from First Cohort in Phase 1 TTX-MC138 Clinical Trial

Form EFFECT - Notice of Effectiveness

Form D - Notice of Exempt Offering of Securities

Form S-1 - General form for registration of securities under the Securities Act of 1933

Form 8-K - Current report

TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split

RNAZ Discussion

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free